Atrys Health SL (ATRY) - Total Liabilities

Latest as of December 2025: €342.08 Million EUR ≈ $399.93 Million USD

Based on the latest financial reports, Atrys Health SL (ATRY) has total liabilities worth €342.08 Million EUR (≈ $399.93 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ATRY net asset momentum to track the company's year-over-year net asset growth rate.

Atrys Health SL - Total Liabilities Trend (2012–2025)

This chart illustrates how Atrys Health SL's total liabilities have evolved over time, based on quarterly financial data. See ATRY cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Atrys Health SL Competitors by Total Liabilities

The table below lists competitors of Atrys Health SL ranked by their total liabilities.

Company	Country	Total Liabilities
CSG Holding Co Ltd SHE:200012	China	HK$18.01 Billion
TBI Motion Technology Co Ltd TW:4540	Taiwan	NT$4.15 Billion
Gyldendal A/S CO:GYLD-A	Denmark	Dkr290.27 Million
China Glaze Co Ltd TW:1809	Taiwan	NT$1.21 Billion
Aekyung Industrial Co Ltd KO:018250	Korea	₩82.54 Billion
Imagesat International ISI Ltd TA:ISI	Israel	ILA76.08 Million
Holiday Entertainment Co Ltd TW:9943	Taiwan	NT$2.09 Billion
Bin Chuan Enterprise Co Ltd TWO:1569	Taiwan	NT$3.53 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Atrys Health SL's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ATRY market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.81	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.25	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Atrys Health SL's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Atrys Health SL (2012–2025)

The table below shows the annual total liabilities of Atrys Health SL from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	€342.08 Million ≈ $399.93 Million	+3.36%
2024-12-31	€330.95 Million ≈ $386.92 Million	-2.41%
2023-12-31	€339.12 Million ≈ $396.47 Million	-7.77%
2022-12-31	€367.71 Million ≈ $429.89 Million	+26.08%
2021-12-31	€291.65 Million ≈ $340.97 Million	+190.35%
2020-12-31	€100.45 Million ≈ $117.43 Million	+108.88%
2019-12-31	€48.09 Million ≈ $56.22 Million	+76.47%
2018-12-31	€27.25 Million ≈ $31.86 Million	+61.25%
2017-12-31	€16.90 Million ≈ $19.76 Million	+3.64%
2016-12-31	€16.31 Million ≈ $19.06 Million	+13.27%
2015-12-31	€14.40 Million ≈ $16.83 Million	+14.17%
2014-12-31	€12.61 Million ≈ $14.74 Million	+2.90%
2013-12-31	€12.25 Million ≈ $14.33 Million	+0.14%
2012-12-31	€12.24 Million ≈ $14.31 Million	--

About Atrys Health SL

MC:ATRY Spain Biotechnology

Market Cap

$236.09 Million

€201.94 Million EUR

Market Cap Rank

#16517 Global

#109 in Spain

Share Price

€2.66

Change (1 day)

+1.92%

52-Week Range

€2.34 - €3.51

All Time High

€11.20